Related Experiment Video
Updated: Mar 12, 2026
03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.6K
Atypical ulcers in the inpatient setting evaluated by special consult services
Jason R Hernandez1, Kyaw Zin Htet2, Jade N Young1
1Oregon Health & Science University School of Medicine, Portland, Oregon, US.
Journal of Wound Care
|March 11, 2026
Summary
Inpatients with atypical cutaneous ulcers often have multiple health issues and a higher mortality risk. These non-diabetic, non-pressure ulcers frequently require care from multiple medical specialists.
Area of Science:
- Dermatology
- Vascular Surgery
- Infectious Disease
- Plastic Surgery
Background:
- Inpatient ulcers are typically pressure-induced or diabetic.
- Research often overlooks atypical ulcer etiologies in hospitalized patients.
- Atypical ulcers include inflammatory, neoplastic, vascular, infectious, drug-induced, or multifactorial causes.
Purpose of the Study:
- To characterize patients with atypical cutaneous ulcers in an inpatient setting.
- To identify non-diabetic, non-pressure ulcers requiring specialty consultation.
Main Methods:
- Retrospective review of inpatient cutaneous ulcer consultations.
- Data collected from vascular surgery, plastic surgery, infectious disease, and dermatology databases.
- Study period: October 2015 to November 2020 at Oregon Health & Science University.
Main Results:
- 120 out of 322 patients were included.
- Mean age was 52.46 years; 54.2% were female.
- Most common etiologies: multifactorial (30%), infectious (23.3%), inflammatory (17.5%).
- 95% had comorbidities; 8.3% were homeless.
- 18.3% of patients were deceased at review.
Conclusions:
- Atypical ulcers in inpatients are associated with comorbidities and increased mortality.
- These ulcers often necessitate complex, multispecialty care.
- Prospective research is needed to identify predisposing factors for morbidity and mortality.
Related Concept Videos
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
735
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
735
01:26Peptic Ulcer Disease IV: Management
601
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
601
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
1.1K
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
1.1K
01:30Peptic Ulcer Disease I: Introduction
979
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
979
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.8K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.8K
01:28Peptic Ulcer Disease II: Pathophysiology
2.4K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K